News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Catabasis Pharmaceuticals, Inc. To Present CAT-2003 Data At Upcoming Lipid Conferences


4/25/2014 7:04:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Catabasis Pharmaceuticals Inc. today announced the upcoming presentation of clinical and preclinical data for its lead candidate, CAT-2003, further defining its mechanism of action in the treatment of severe hypertriglyceridemia and chylomicronemia syndromes. Data from the Phase 1 study of CAT-2003 will be presented in an oral session at the National Lipid Association (NLA) Scientific Sessions 2014 in Orlando, FL, and preclinical data will be presented in one oral session and one poster session at the Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) 2014 Scientific Sessions in Toronto, Ontario.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES